Best Healthcare Companies in British Columbia, Canada
The 351 best Healthcare companies in British Columbia, Canada in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Correvio.
Ranked: Best Healthcare companies in British Columbia
| # | Company | Disclosed funding | Last round | Employees | Founded | Founder | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|
| 1 | Correvio Manufacturer of generic solid and liquid dosage forms | $130M | 87 mo ago | 133 | 1986 | — | — | — |
| 2 | VetCare Standalone veterinary clinic | $100M | 40 mo ago | 32 | 2016 | — | — | 3 job openings |
| 3 | adMare BioInnovations Provider of biopharma consulting services | $92M | 50 mo ago | 152 | 2019 | — | 4 patents Small‑molecule therapeutics targeting bone formation disorders (FOP, Cyp26b1 inhibition). | 1 job opening · 1 internship · 1 expansion |
| 4 | Emerald Health Therapeutics Producer and supplier of medical cannabis products | $67M | 74 mo ago | 23 | 2007 | — | 33 patents Enhanced cannabinoid delivery, bioavailability, and combination pharmaceutical formulations. | — |
| 5 | Brainsbioceutical Manufacturer of pharmaceutical-grade cannabinoid APIs | $62M | 60 mo ago | 12 | — | — | — | — |
| 6 | AgraFlora Manufacturer of cannabis based products | $50M | 78 mo ago | — | 2004 | Brandon Boddy CEO | — | — |
| 7 | TransCanna Provider of cannabis focused advertising ,marketing, and products distribution services | $34M | 46 mo ago | — | 2017 | Bob Blink CEO | — | — |
| 8 | InMed Pharma Drug discovery and development company uniquely focused on the therapeutic potential of cannabinoids | $23M | 42 mo ago | 18 | 1981 | Sazzad Hossain Co-Founder | — | — |
| 9 | Sproutly Processor and supplier of water-soluble cannabis solutions and bio-natural oils | $23M | 63 mo ago | 27 | 2013 | — | — | — |
| 10 | YYoga Yoga studio and lifestyle centers | $22M | 151 mo ago | 381 | 2008 | — | — | 2 expansions |
| 11 | ImmunoPrecise Antibodies CDMO focused on antibody discovery and pre-clinical services | $18M | 23 mo ago | 80 | 1989 | Chris Buyse Board of Directors | 5 patents Monoclonal antibody production and diagnostics for estrogen receptors and muscular dystrophy biomarkers | — |
| 12 | Response Biomedical develops, manufactures and markets rapid on-site diagnostic tests. | $15M | 152 mo ago | 64 | 1992 | — | 62 patents Multiplex immunoassay platforms for rapid, calibrated diagnostic testing of multiple biomarkers. | 6 launchs |
| 13 | Algernon Pharmaceuticals Developer of small molecules for chronic kidney disease and inflammatory bowel diseases | $13M | 7 mo ago | 1 | 2015 | — | 44 patents Small-molecule drugs for liver, kidney, and CNS disorders (e.g., NASH, fibrosis, brain injury) | — |
| 14 | Anandia Provider of cannabis genomics, analytics, and plant breeding services | $11M | 101 mo ago | 90 | 2013 | — | — | — |
| 15 | GTEC Laboratory focused on providing cannabis testing services | $11M | 86 mo ago | — | 2017 | Michael Blady Co-Founder & VP & Director | — | — |
| 16 | iCo Therapeutics Reformulated drugs for infectious diseases and immune diseases. | $9M | 81 mo ago | 6 | 2005 | — | 24 patents Oral delivery formulations and administration methods for amphotericin B antifungal therapy | — |
| 17 | Sixth Wave Firm focused on extraction polymers for the gold mining industry | $8M | 53 mo ago | 11 | 2013 | Jonathan Gluckma Founder & CEO | — | — |
| 18 | Sirona Biochem Developer of therapeutics for the treatment of skincare | $7M | 13 mo ago | 11 | 2006 | Howard Verrico CEO | — | — |
| 19 | Eden Empire Provider of cannabis focused consulting services | $7M | 81 mo ago | 200 | 2011 | Gerry Trapasso CEO | — | — |
| 20 | Nextleaf Solutions Provides cannabis and hemp processing services | $6M | 62 mo ago | 26 | 2017 | Paul Pedersen Co-Founder & CEO | 120 patents Cannabinoid extraction, chilled filtration, and spent cannabis biomass processing technologies. | — |
| 21 | Burb Manufacturer of cannabis and accessories | $5M | 56 mo ago | 29 | 2018 | John Kaye Co-Founder & CEO | — | — |
| 22 | Providence Health Care Health system | $5M | 195 mo ago | 5,412 | 1997 | Fiona Dalton CEO & President | — | 5 job openings |
| 23 | Chemokine Therapeutics Developer of chemokine therapies | $5M | — | — | 1998 | Hassan Salari Founder & President | 16 patents Therapeutic chemokine and cyclic peptide analogs for angiogenesis and hematopoietic modulation | — |
| 24 | Langley Hospice Society Provider of palliative and bereavement care and support to the community. | $5M | 111 mo ago | — | 1983 | Dorscie Paterson Founder | — | 2 job openings |
| 25 | Kovo Provider of healthcare technology and revenue cycle management services | $5M | 37 mo ago | 67 | 2013 | Greg Noble CEO | — | — |
| 26 | Element Provider of management and consulting services for retirement communities | $5M | 108 mo ago | 12 | 1995 | Michael Diao CEO | 276 patents AI-driven computer vision and document analysis, focusing on training, anomaly detection, and OCR. | — |
| 27 | Optimi Health Manufacturer of vegan protein | $4M | 11 mo ago | — | 2020 | Bill Ciprick Chief Executive Officer | — | 4 launchs · 1 expansion |
| 28 | Better Plant Sciences Brand of diversified cannabis health & wellness products | $4M | 87 mo ago | 2 | 2014 | Cole Drezdoff CEO | — | — |
| 29 | Mota Ventures Producer, exporter and distributor of CBD products | $3M | 73 mo ago | — | 2010 | Ryan Hoggan CEO | — | — |
| 30 | Arthritis Research Canada Company conducting and coordinating clinical trials for arthritis treatment | $3M | 141 mo ago | 68 | 2000 | John Esdaile Founder | — | 1 job opening |
| 31 | Gaia Grow Producer and retailer of medical cannabis products | $2M | 56 mo ago | — | 2014 | Frederick Pels Co-Founder & President & Director | — | — |
| 32 | Arbutus Medical Manufacturer of orthopedic surgical tools and devices | $2M | 14 mo ago | 25 | 2014 | Michael Cancilla Sr. Director of Product | 20 patents Orthopedic traction pin systems for bone fixation and surgical device components | — |
| 33 | ALAViDA Provider of healthcare platform services | $2M | 97 mo ago | — | 2016 | Terri-Lynn MacKay Co-Founder | — | — |
| 34 | KGH Foundation Provider of diversified home healthcare services | $2M | 108 mo ago | — | 1978 | Allison Ramchuk CEO | — | 1 job opening |
| 35 | CuePath Developer of medication monitoring platform connecting seniors with care professionals | $2M | 103 mo ago | 16 | 2015 | Ivan Spogreev Co-Founder | — | — |
| 36 | The BC Bud Co Provider of cannabis cultivators services | $2M | 16 mo ago | 6 | 2019 | TJ Taylor Co-Founder | — | — |
| 37 | Andira Digital pharmacotherapeutic platform for providers 21Funding top 50%Talent bottom 49%Market bottom 37%Global bottom 29% All 4 signals ▾Fundingtop 50% Talentbottom 49% Marketbottom 37% Globalbottom 29% Funding: Raised $1.4M across 5 rounds · 5 rounds over 4 yrs (1.2/yr) Talent: 1 named leader on record · 1 C-suite/founder profile curated rank vs industry peers · Fliar Intelligence Index 21/100 | $1M | 3 mo ago | — | 2020 | Dana Lambert Chief Executive Officer | — | — |
| 38 | UniDoc Health Provider of tele healthcare services | $1M | 7 mo ago | — | 2008 | Antonio Baldassarre CEO | — | — |
| 39 | Christina Lake Cannabis Provider of sun-grown cannabis flower, oil cannabinoids, hemp-based extracts, and derivatives 19Funding top 44%Tech top 50%Talent bottom 49%Market bottom 25% All 6 signals ▾Fundingtop 44% Techtop 50% Talentbottom 49% Marketbottom 25% Globalbottom 25% Newsbottom 22% Funding: Raised $1.4M across 9 rounds · 9 rounds over 6 yrs (1.5/yr) Tech: 25 technologies across 4/8 capability areas · Cloud: Cloudflare rank vs industry peers · Fliar Intelligence Index 19/100 | $1M | 13 mo ago | 12 | 2018 | Mark Aiken CEO | — | — |
| 40 | Allied Health Medical cannabis supplier delivering pharmaceutical-grade solutions worldwide 11Funding top 44%Talent bottom 49%Market bottom 34%Growth bottom 32% All 6 signals ▾Fundingtop 44% Talentbottom 49% Marketbottom 34% Growthbottom 32% Globalbottom 30% Fin. healthbottom 15% Funding: Raised $1.4M across 9 rounds · 9 rounds over 7 yrs (1.3/yr) Talent: 1 named leader on record · 1 C-suite/founder profile curated rank vs industry peers · Fliar Intelligence Index 11/100 | $1M | 19 mo ago | 165 | 2019 | Calum Hughes Founder & CEO | — | — |
| 41 | Universal Ibogaine Standalone treatment & therapy clinic | $1M | 26 mo ago | 12 | 2018 | Nick Karos CEO | — | — |
| 42 | Delic Chain of psychedelic wellness clinics | $1M | 46 mo ago | 2 | 2018 | — | — | — |
| 43 | THC BioMed Developer of medical cannabis products | $1M | 102 mo ago | 35 | 1982 | John Miller CEO | — | — |
| 44 | GuideStar Medical Devices Designs and manufactures medical devices | $472K | 15 mo ago | — | 2019 | Mike Dolphin CEO | 12 patents Spinal anesthesia guidance devices for epidural needle detection and placement | — |
| 45 | Greenrise Global Provider of medical cannabis and wellness therapy services | $449K | 50 mo ago | 193 | 2021 | — | — | — |
| 46 | Jolt Health Manufacturer of drugs | $444K | 26 mo ago | — | 2023 | Gerald Tritt CEO | — | — |
| 47 | Captiva Verde Provider of cannabis medical services | $203K | 33 mo ago | — | 2015 | Jeffrey Ciachurski CEO | — | — |
| 48 | Vatic Ventures Operator of mineral exploration projects focused on strategic mineral resources | $120K | 17 mo ago | — | 2007 | Gerry Wright CEO & Director | — | — |
Top 12 Healthcare companies in British Columbia
#1
Public · Vancouver, British Columbia · founded 2015 · 1 employees$12.8Mraised▾
Algernon Pharmaceuticals is a developer of small molecules for chronic kidney disease and inflammatory bowel diseases. The company is using a drug repurposing strategy to discover drugs. The lead candidate, NP-135 is an antifibrotic compound being investigated for NASH (phase 1). Other molecules are in phase 1 trials for CKD and IBD.
- Nov 2025Post IPO$607.7K
- May 2025Post IPO$554.6K
- Jul 2024Post IPO$299.4K
- Apr 2024Post IPO$12.6K
#2
Seed · Vancouver, British Columbia · founded 2020$1.4Mraised▾
Digital pharmacotherapeutic platform for providers. It is a platform for the discovery and creation of natural chemicals with the potential for medicinal usage.
- Feb 2026Seed$152.4K
- Aug 2024Seed$809.9K
- Jun 2024Seed$18.3K
- Oct 2023Seed$212K
#3
Public · Vancouver, British Columbia · founded 2006 · 11 employees$7.4Mraised▾
Developer of therapeutics for the treatment of skincare. The company is developing anti-aging and anti-wrinkle molecule, TFC-1326, as GlycoProteMim to preserve and restore youthful skin and reverse aging.
- Apr 2025Post IPO$2.2M
- Apr 2024Post IPO$97.8K
- Jul 2019Post IPO$1.1M
- Feb 2019Post IPO$1.8M
#4
Public · Vancouver, British Columbia · founded 2020$4.5Mraised▾
Manufacturer of vegan protein
#5
Public · Vancouver, British Columbia · founded 2008$1.4Mraised▾
Provider of tele healthcare services
- Oct 2025Post IPO$1.1M
- Apr 2025Post IPO$353.7K
#6
Public · Victoria, British Columbia · founded 1989 · 80 employees$18.4Mraised▾
CDMO focused on antibody discovery and pre-clinical services
- Jul 2024Post IPO$2M
- Jul 2020Grant (prize money)—
- Apr 2020Post IPO$1.8M
- Apr 2020Grant (prize money)$75K
#7
Seed · Vancouver, British Columbia · founded 2014 · 25 employees$2.3Mraised▾
Manufacturer of orthopedic surgical tools and devices
- Mar 2025Seed$406.2K
- Feb 2023Seed$2.3M
- Jul 2016Grant (prize money)$1M
#8
Public · Vancouver, British Columbia · founded 2018 · 12 employees$1.4Mraised▾
Provider of sun-grown cannabis flower, oil cannabinoids, hemp-based extracts, and derivatives. It is a licensed producer of cannabis under the Cannabis Act. It has secured a standard cultivation licence and corresponding processing & sales amendment from Health Canada as well as a research and development licence. It claims that products are natural and healthy.
- Apr 2025Post IPO$824.1K
- Dec 2024Post IPO$861.5K
- Nov 2024Post IPO$1.3M
- Feb 2024Post IPO$1.4M
#9
Public · Vancouver, British Columbia · founded 2019 · 6 employees$1.6Mraised▾
Provider of cannabis cultivators services
- Jan 2025Post IPO$351.7K
- Jan 2025Post IPO$788.4K
- Apr 2024Post IPO$400K
- Aug 2023Post IPO$52.5K
#10
Series D · Vancouver, British Columbia · founded 2016 · 32 employees$100Mraised▾
Standalone veterinary clinic
- Jan 2023Series D$100M
- Aug 2021Conventional Debt—
#11
Public · Kelowna, British Columbia · founded 2019 · 165 employees$1.4Mraised▾
Medical cannabis supplier delivering pharmaceutical-grade solutions worldwide. The company is a trusted provider of high-quality medical cannabis to pharmaceutical partners globally. Leveraging cultivation expertise and strict pharmaceutical standards, combined with optimal growing conditions, they offer a consistent supply of high-quality cannabis products to key medical markets. Their proven supply chain ensures reliable access for partners, always keeping the needs of patients at the forefront. The company focuses on consistent and reliable supply of medical cannabis to pharmaceutical companies globally, aiming to make cannabis a primary source of medicine accessible to all and improve patient lives throughout the world. They offer smokeable flower, extracts, finished products, gummies, live rosin, and vape cartridges. The company adheres to stringent pharmaceutical standards, ensuring product safety for patients worldwide.
- Nov 2024Post IPO$384.6K
- Oct 2024Post IPO$215.6K
- Aug 2024Post IPO$1.3M
- Apr 2024Post IPO$600K
#12
Funding Raised · Vancouver, British Columbia · founded 2019 · 152 employees$92Mraised▾
Provider of biopharma consulting services
- Mar 2022Grant (prize money)$92M
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Healthcare coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising